Baseline clinical and neuroimaging biomarkers of treatment response to high-frequency rtms over the left dlpfc for resistant depression

HIGHLIGHTS

• who: Ghina Harika-Germaneau from the Centre Hospitalier Henri Laborit, Unitu00e9 de Recherche Clinique Pierre Deniker, France, Centre de Recherches sur la University of Tehran, Tehran, Iran, Atieh Clinical Neuroscience Centre, Tehran, Iran, CHU, Service de Mu00e9decine have published the paper: Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression, in the Journal: (JOURNAL)
• what: In this retrospective and naturalistic study, the authors aimed to identify clinical and neuroimaging factors associated with the efficacy of rTMS evaluated 1 month after the beginning of treatment in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.